Cargando…
COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. Unfortunately, the degree of inflammation produced by COVID-19 mRN...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145134/ https://www.ncbi.nlm.nih.gov/pubmed/37112659 http://dx.doi.org/10.3390/vaccines11040747 |
_version_ | 1785034260284964864 |
---|---|
author | Giannotta, Girolamo Murrone, Antonio Giannotta, Nicola |
author_facet | Giannotta, Girolamo Murrone, Antonio Giannotta, Nicola |
author_sort | Giannotta, Girolamo |
collection | PubMed |
description | Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. Unfortunately, the degree of inflammation produced by COVID-19 mRNA vaccines is variable, probably depending on genetic background and previous immune experiences, which through epigenetic modifications could have made the innate immune system of each individual tolerant or reactive to subsequent immune stimulations.We hypothesize that we can move from a limited pro-inflammatory condition to conditions of increasing expression of pro-inflammatory cytokines that can culminate in multisystem hyperinflammatory syndromes following COVID-19 mRNA vaccines (MIS-V). We have graphically represented this idea in a hypothetical inflammatory pyramid (IP) and we have correlated the time factor to the degree of inflammation produced after the injection of vaccines. Furthermore, we have placed the clinical manifestations within this hypothetical IP, correlating them to the degree of inflammation produced. Surprisingly, excluding the possible presence of an early MIS-V, the time factor and the complexity of clinical manifestations are correlated to the increasing degree of inflammation: symptoms, heart disease and syndromes (MIS-V). |
format | Online Article Text |
id | pubmed-10145134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101451342023-04-29 COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events Giannotta, Girolamo Murrone, Antonio Giannotta, Nicola Vaccines (Basel) Review Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. Unfortunately, the degree of inflammation produced by COVID-19 mRNA vaccines is variable, probably depending on genetic background and previous immune experiences, which through epigenetic modifications could have made the innate immune system of each individual tolerant or reactive to subsequent immune stimulations.We hypothesize that we can move from a limited pro-inflammatory condition to conditions of increasing expression of pro-inflammatory cytokines that can culminate in multisystem hyperinflammatory syndromes following COVID-19 mRNA vaccines (MIS-V). We have graphically represented this idea in a hypothetical inflammatory pyramid (IP) and we have correlated the time factor to the degree of inflammation produced after the injection of vaccines. Furthermore, we have placed the clinical manifestations within this hypothetical IP, correlating them to the degree of inflammation produced. Surprisingly, excluding the possible presence of an early MIS-V, the time factor and the complexity of clinical manifestations are correlated to the increasing degree of inflammation: symptoms, heart disease and syndromes (MIS-V). MDPI 2023-03-28 /pmc/articles/PMC10145134/ /pubmed/37112659 http://dx.doi.org/10.3390/vaccines11040747 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Giannotta, Girolamo Murrone, Antonio Giannotta, Nicola COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events |
title | COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events |
title_full | COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events |
title_fullStr | COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events |
title_full_unstemmed | COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events |
title_short | COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events |
title_sort | covid-19 mrna vaccines: the molecular basis of some adverse events |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145134/ https://www.ncbi.nlm.nih.gov/pubmed/37112659 http://dx.doi.org/10.3390/vaccines11040747 |
work_keys_str_mv | AT giannottagirolamo covid19mrnavaccinesthemolecularbasisofsomeadverseevents AT murroneantonio covid19mrnavaccinesthemolecularbasisofsomeadverseevents AT giannottanicola covid19mrnavaccinesthemolecularbasisofsomeadverseevents |